Biosynthesis of serotonergic Kanna alkaloids
Plants have repeatedly evolved to synthesize natural products that exploit serotonin signaling in animals. Although serotonin and most of its neuroactive analogs derive from tryptophan, the medicinal Kanna plant (Mesembryanthemum tortuosum) instead uses tyrosine and phenylalanine to construct a serotonin-like scaffold through unknown chemical transformations. Here, we elucidate the biosynthesis of Kanna alkaloids, including the serotonin reuptake inhibitor mesembrine. We reveal an unusual scaffold-forming strategy that is mediated by non-canonical transferase and oxidase enzymes, and we provide mechanistic insight on how an activated biosynthetic intermediate undergoes a multistep cyclization cascade to form the Kanna alkaloid scaffold. Collectively, our work uncovers how plants repurpose unconventional metabolic building blocks and enzymes to produce serotonergic molecules with promise as therapeutics for neurological disorders.
Authors
- Colin Y. Kim (ORCID: https://orcid.org/0000-0001-9583-9789)
- Ryan S. Nett (ORCID: https://orcid.org/0000-0002-2537-7010)
Institutions
- Harvard University (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.13.766392
- Primary Topic
- Plant biochemistry and biosynthesis
- Type
- preprint
Funders
- National Science Foundation
- Harvard University
- Korea Advanced Institute of Science and Technology
- National Institutes of Health